Details of the Drug-Related molecule(s) Interaction Atlas

AC1LCOK0 Drug Info

CHEMBL349763; 2-(2-Iodo-phenyl)-6,7-dimethoxy-benzo[d][1,3]oxazin-4-one; 2-(2-Iodophenyl)-6,7-dimethoxy-4H-3,1-benzoxazin-4-one; BAS 00763013; AC1LCOK0; Oprea1_230794; Oprea1_104130; SCHEMBL913416; HKRJBRGRGFMQJI-UHFFFAOYSA-N; ZINC832897; STK295881; BDBM50289001; AKOS000642901; MCULE-9727934711; ST50239885; AB00095356-01; SR-01000441631; SR-01000441631-1; 2-(2-iodophenyl)-6,7-dimethoxy-3,1-benzoxazin-4-one; 2-(2-iodophenyl)-6,7-dimethoxybenzo[d]1,3-oxazin-4-one; 2-(2-Iodophenyl)-6,7-dimethoxy-4H-3,1-benzoxazin-4-one #

Cross-matching ID

PubChem CID

634264

TTD Drug ID

DMFWYKE

General Information of Drug (ID: DMFWYKE)

Molecule-Related Drug Atlas

Molecule Type:

DTT

Drug Status:

Patented Agent(s)

Investigative Drug(s)

Download the Complete Related Drug List

Drug(s) Targeting Chymotrypsin-C (CLCR)

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
Z223457004	DMUOZEJ	N. A.	N. A.	Patented	[1]
STK296197	DM6KPYL	N. A.	N. A.	Patented	[1]
Z90308237	DMRBFUA	N. A.	N. A.	Patented	[1]
PMID12372533C20	DMIW5TY	Discovery agent	N.A.	Investigative	[2]
------------------------------------------------------------------------------------

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Download the Complete Interaction Atlas for Visualization in Cytoscape

Drug Therapeutic Target (DTT)

References

1	Benzoxazinone derivatives for treatment of skin diseases. US9695194.
2	P1 Phenethyl peptide boronic acid inhibitors of HCV NS3 protease. Bioorg Med Chem Lett. 2002 Nov 4;12(21):3199-202.